These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Samuelsson A; Towers TL; Ravetch JV Science; 2001 Jan; 291(5503):484-6. PubMed ID: 11161202 [TBL] [Abstract][Full Text] [Related]
3. Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages. Arikawa T; Watanabe K; Seki M; Matsukawa A; Oomizu S; Sakata KM; Sakata A; Ueno M; Saita N; Niki T; Yamauchi A; Hirashima M Clin Immunol; 2009 Dec; 133(3):382-92. PubMed ID: 19800850 [TBL] [Abstract][Full Text] [Related]
4. IgG Glyco-Engineering to Improve IVIg Potency. Bruggeman CW; Dekkers G; Visser R; Goes NWM; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW Front Immunol; 2018; 9():2442. PubMed ID: 30405631 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg. Song S; Crow AR; Siragam V; Freedman J; Lazarus AH Blood; 2005 Feb; 105(4):1546-8. PubMed ID: 15479722 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. Campbell IK; Miescher S; Branch DR; Mott PJ; Lazarus AH; Han D; Maraskovsky E; Zuercher AW; Neschadim A; Leontyev D; McKenzie BS; Käsermann F J Immunol; 2014 Jun; 192(11):5031-8. PubMed ID: 24760152 [TBL] [Abstract][Full Text] [Related]
7. Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs. Fiebiger BM; Maamary J; Pincetic A; Ravetch JV Proc Natl Acad Sci U S A; 2015 May; 112(18):E2385-94. PubMed ID: 25870292 [TBL] [Abstract][Full Text] [Related]
9. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455 [TBL] [Abstract][Full Text] [Related]
10. The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia. Crow AR; Suppa SJ; Chen X; Mott PJ; Lazarus AH Blood; 2011 Dec; 118(24):6403-6. PubMed ID: 22001393 [TBL] [Abstract][Full Text] [Related]
11. Macrophages activated by C-reactive protein through Fc gamma RI transfer suppression of immune thrombocytopenia. Marjon KD; Marnell LL; Mold C; Du Clos TW J Immunol; 2009 Feb; 182(3):1397-403. PubMed ID: 19155486 [TBL] [Abstract][Full Text] [Related]
12. GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out. Lewis BJB; Leontyev D; Neschadim A; Blacquiere M; Branch DR Clin Exp Immunol; 2018 Sep; 193(3):293-301. PubMed ID: 29704458 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Siragam V; Crow AR; Brinc D; Song S; Freedman J; Lazarus AH Nat Med; 2006 Jun; 12(6):688-92. PubMed ID: 16715090 [TBL] [Abstract][Full Text] [Related]